Companies › PCSA
PROCESSA PHARMACEUTICALS INC (PCSA)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001533743 · EDGAR filings · Updated 2026-07-28
PROCESSA PHARMACEUTICALS INC (PCSA) has reported institutional ownership of 6.7%, with 10 institutional managers holding positions valued at $448.5K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (6)
- 2026-07-28 — Insider transaction reported (Form 4)
- 2026-07-28 — Insider transaction reported (Form 4)
- 2026-07-28 — Insider transaction reported (Form 4)
- 2026-07-28 — Insider transaction reported (Form 4)
- 2026-07-28 — Insider transaction reported (Form 4)
- 2026-07-28 — Insider transaction reported (Form 4)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, PROCESSA PHARMACEUTICALS INC has 10 institutional holders and institutional ownership of 6.7%.
Insider activity
Insiders reported 11 transactions (0 buys, 0 sells) across 6 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
GeoVax Labs Inc (GOVX) · CADRENAL THERAPEUTICS INC (CVKD) · XENETIC BIOSCIENCES INC (XBIO) · Pulmatrix Inc (PULM) · ENDRA LIFE SCIENCES INC (NDRA) · POLYRIZON LTD (PLRZ)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.